Literature DB >> 10081879

Urodynamic findings in adults with the tethered cord syndrome.

J L Giddens1, S B Radomski, E D Hirshberg, M Hassouna, M Fehlings.   

Abstract

PURPOSE: We evaluated bladder function in adults with the tethered cord syndrome using multichannel urodynamics.
MATERIALS AND METHODS: A total of 21 patients a mean 39.6 years old (range 20 to 62) with a tethered cord were evaluated. Of the patients 13 were diagnosed with a tethered cord as an adult and 8 had undergone previous spinal surgery. The tethered cord syndrome was diagnosed by magnetic resonance imaging in 20 patients and computerized tomography myelogram in 1. All patients underwent complete neurological and urological evaluation, including multichannel urodynamics. Needle electromyography and video urodynamics were performed in select cases. Microsurgical release of the tethered cord was performed in 19 patients and 2 refused surgery. Urodynamics were done before surgery in 16 of 19 patients and a median of 12.5 months (range 1 to 40) after surgery in 14. In addition, intraoperative urodynamic monitoring and nerve root stimulation were done in 14 patients to prevent nerve root injury at surgery.
RESULTS: At presentation urgency (67%) and urge incontinence (50%) were the most common findings in 18 patients with urinary symptoms. Pretreatment urodynamics in 18 of 21 patients revealed hyperreflexia in 13 (72%), external detrusor-sphincter dyssynergia in 4 (22%), decreased sensation in 4 (22%), decreased compliance in 3 (17%) and hypocontractile detrusor in 2 (11%). Postoperative urodynamic findings were improved in 4 patients (29%) and unchanged in 10 (71%). Preoperative external detrusor-sphincter dyssynergia in 4 patients resolved postoperatively in 3 and was unchanged in 1. Urinary symptoms were improved in 19% of patients (4), unchanged in 76% (16) and worse in 5% (1). To date 7 patients require anticholinergics, 4 require clean intermittent catheterization and 1 is taking an alpha-blocker.
CONCLUSIONS: Adults with the tethered cord syndrome are less likely to have urodynamic or symptom improvement after cord release and most often present with irreversible findings which rarely become worse after surgery. These patients need to have careful and continuous followup, including urodynamic studies, due to possible re-tethering with time.

Entities:  

Mesh:

Year:  1999        PMID: 10081879

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Neurogenic bladder due to a tethered spinal cord.

Authors:  Joon Seok Choi; Jeong Woo Park; Soo Wan Kim
Journal:  Clin Exp Nephrol       Date:  2012-07-10       Impact factor: 2.801

2.  Normal ranges of variability for urodynamic studies of neurogenic bladders in spinal cord injury.

Authors:  Franklin H Chou; Chester H Ho; M B Chir; Todd A Linsenmeyer
Journal:  J Spinal Cord Med       Date:  2006       Impact factor: 1.985

3.  Tethered cord syndrome in a 24-year-old woman presenting with urinary retention.

Authors:  Basir Tareen; Mark Memo; Jeff Cerone; Raymond Bologna; Robert Flora
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-09-12

Review 4.  Surgery in adult onset tethered cord syndrome (ATCS): review of literature on occasion of an exceptional case.

Authors:  K Aufschnaiter; F Fellner; G Wurm
Journal:  Neurosurg Rev       Date:  2008-05-28       Impact factor: 3.042

5.  Prevalence of Spina Bifida Occulta and Its Relationship With Overactive Bladder in Middle-Aged and Elderly Chinese People.

Authors:  Jun Wei Wu; Yu Rong Xing; Yi Bo Wen; Tian Fang Li; Jia Feng Xie; Quan De Feng; Xiao Ping Shang; Yun Long Li; Jin Jin Feng; Xin Xin Wang; Rong Qun Zhai; Xiang Fei He; Tao Chen; Xin Jian Liu; Jian Guo Wen
Journal:  Int Neurourol J       Date:  2016-06-24       Impact factor: 2.835

6.  Scoliosis may be the first symptom of the tethered spinal cord.

Authors:  Mustafa Barutçuoğlu; Mehmet Selçuki; Ahmet Sukru Umur; Mesut Mete; Seren Gulsen Gurgen; Deniz Selcuki
Journal:  Indian J Orthop       Date:  2016 Jan-Feb       Impact factor: 1.251

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.